Featured Stories
Maja Strnad Cestar has been appointed as the new CEO
Upcoming Changes in Medis Leadership
Martina Perharič, the current CEO of Medis, will transition to a new role as Chief Business Officer (CBO) of Pharmaceuticals, effective 1 August 2023. At the...
Read MoreDiscover the potential
Combining Forces to Reach Patients with Rare Diseases Across the Globe
World Orphan Drug Alliance (WODA) is a new global alliance of full-service regional distributors for orphan drugs.
Read MoreNew partnership
Medis and PAION Have Signed Commercialization Agreement for Three Innovative Hospital Therapies
Medis will be an exclusive partner for the commercialization of three innovative products in 9 different markets across the CEE region.
Read MoreExclusive Partnership
Long-Term Partnership with Salix in the Therapeutic Area of Digestive Health
Medis has signed a long-term agreement with Salix for the commercialization of a new and innovative digestive health product in 11 different countries across...
Read MoreMedis will Commercialize Orphan Drug NaMuscla® in Central and Eastern European Countries
Medis will initially focus on the commercialization of NaMuscla® in Croatia, Czech Republic, Hungary, Slovakia, and Slovenia.
Read MoreWe wish you a winning 2022
The Ode to the Winners was composed by Drago Ivanuša in November 2021 in honour of all the doctors and pharmacists who participate in the International Medis...
Read More